We can’t show the full text here under this license.
Nutritional Risks After Gastric Bypass Revealed by Diabetes Drug Treatment
Updated
Abstract
Essence
Semaglutide may expose severe nutritional risk in some patients after .
Evidence
This single case report describes a post-Roux-en-Y gastric bypass patient who developed life-threatening malnutrition, micronutrient deficiencies, and acute liver injury after semaglutide initiation, requiring ICU care, parenteral nutrition, and endoscopic bypass reversal.
Caveat
A single case can flag a plausible safety concern but cannot estimate frequency, prove causality, or define which postbariatric patients are at highest risk.
Simplified
Key numbers
profound deficiencies in fat-soluble vitamins (A, D, E), trace elements (zinc and copper), and vitamin B6
Micronutrient Deficiencies
Patient's micronutrient studies revealed deficiencies after GLP-1 therapy initiation.
AST 123 U/L
Admission Liver Enzymes
Laboratory results showed elevated liver enzymes upon admission.
1.9 g/dL
Admission Albumin Level
Albumin levels were critically low at the time of admission.
GLP-1 Therapies